Financial News
Vascular Biogen. Ord (NQ: VBLT )
1.730
USD
-0.180
(-9.42%)
Official Closing Price
Updated: 6:53 PM EDT, Apr 9, 2021
Add to My Watchlist
Stories about Vascular Biogen. Ord
The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs
April 09, 2021
From Benzinga
From InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday Morning
April 06, 2021
From InvestorPlace
From Benzinga
From Benzinga
Recap: Vascular Biogenics Q4 Earnings
March 25, 2021
From Benzinga
30 Stocks Moving in Thursday's Pre-Market Session
March 25, 2021
From Benzinga
Earnings Scheduled For March 25, 2021
March 25, 2021
From Benzinga
FDA Decisions For Pfizer, Eli Lilly And Bluebird Bio, Bristol-Meyers Squibb, Plus New Data And Earnings
March 20, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO
February 24, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 23, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
February 23, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 23, 2021
From Benzinga
65 Stocks Moving In Tuesday's Mid-Day Session
February 23, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 23, 2021
From Benzinga
48 Stocks Moving in Tuesday's Pre-Market Session
February 23, 2021
From Benzinga
Vascular Biogenics' Ovarian Cancer Gene Therapy Study To Continue, Recommends An Independent Committee
February 22, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 22, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Friday
January 22, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Friday
January 15, 2021
From Benzinga
The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue
January 12, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 11, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Monday
January 11, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Friday
January 08, 2021
From Benzinga
The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs
January 08, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
January 07, 2021
Thursday's morning session saw 641 companies set new 52-week highs. Noteworthy Highlights: Tesla ...
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 07, 2021
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
